China's first infliximab biosimilar drug ready for export, Kexing Biopharm initiated drug registration in 17 countries
2021-07-29
2021-07-29
Kexing Biopharm plans to initiate drug registration in 17 countries, including Brazil, India, Egypt and Indonesia, with some countries expected to start sales in the near future.
Scan Code Consultation
